Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lea Skovgaard"'
Autor:
Roberta Biasiotto, Jennifer Viberg Johansson, Melaku Birhanu Alemu, Virginia Romano, Heidi Beate Bentzen, Jane Kaye, Mirko Ancillotti, Johanna Maria Catharina Blom, Gauthier Chassang, Dara Hallinan, Guðbjörg Andrea Jónsdóttir, Aníbal Monasterio Astobiza, Emmanuelle Rial-Sebbag, David Rodríguez-Arias, Nisha Shah, Lea Skovgaard, Ciara Staunton, Katharina Tschigg, Jorien Veldwijk, Deborah Mascalzoni
Publikováno v:
Journal of Medical Internet Research, Vol 25, p e47066 (2023)
BackgroundWith new technologies, health data can be collected in a variety of different clinical, research, and public health contexts, and then can be used for a range of new purposes. Establishing the public’s views about digital health data shar
Externí odkaz:
https://doaj.org/article/a6b3c4a005304c8689e827d116c24eab
Autor:
Lea Skovgaard, Anders Grundtvig
Publikováno v:
Digital Health, Vol 9 (2023)
Digital health data are seen as valuable resources for the development of better and more efficient treatments, for instance through personalised medicine. However, health data are information about individuals who hold opinions and can challenge how
Externí odkaz:
https://doaj.org/article/f6bc6fc672d843c1a7610dc9ed9f48ae
Autor:
Lea Skovgaard, Mette N. Svendsen
Publikováno v:
New Genetics and Society, Vol 42, Iss 1 (2023)
Personalized medicine aims at tailoring treatment to the individual person through the sourcing of multiple health data from the population. The realization of these ambitions rest on the ability to reuse health data. But what does it take to reuse t
Externí odkaz:
https://doaj.org/article/2f3475f972c44caab904edaf80a36989
Autor:
Lea Skovgaard, Klaus Hoeyer
Publikováno v:
Skovgaard, L L & Hoeyer, K 2022, ' Data authority : Public debate about personalized medicine in Denmark ', Public Understanding of Science, vol. 31, no. 5, pp. 590-607 . https://doi.org/10.1177/09636625221080535
Personalized medicine has generated massive investments in data integration initiatives and stimulated new flows of health data among multiple actors. Such flows raise questions as to who should be able to access data, for which purposes, and how thi